ES2089815T3 - Derivados de bis-aril-carbinol sin enlaces de puente, composiciones y metodos de uso. - Google Patents

Derivados de bis-aril-carbinol sin enlaces de puente, composiciones y metodos de uso.

Info

Publication number
ES2089815T3
ES2089815T3 ES93908326T ES93908326T ES2089815T3 ES 2089815 T3 ES2089815 T3 ES 2089815T3 ES 93908326 T ES93908326 T ES 93908326T ES 93908326 T ES93908326 T ES 93908326T ES 2089815 T3 ES2089815 T3 ES 2089815T3
Authority
ES
Spain
Prior art keywords
group
aril
carbinol
bis
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93908326T
Other languages
English (en)
Inventor
Richard Friary
John J Piwinski
Jesse K Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2089815T3 publication Critical patent/ES2089815T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

SE DESCRIBE UN COMPUESTO DE FORMULA (1.0) O UNA SAL FARMACEUTICAMENTE ACEPTABLE O DISOLUCION DE ELLA, EN DONDE AR1 REPRESENTA (A), AR2 REPRESENTA (B) O UN GRUPO AROMATICO HETEROCICLICO DE CINCO MIEMBROS SELECCIONADO DEL GRUPO COMPUESTO DE FORMULAS (I A XII), EN DONDE LOS ATOMOS DE CARBONO SUSTITUIBLES DEL GRUPO HETEROCICLICO DE CINCO MIEMBROS PUEDE OPCIONALMENTE ESTAR SUSTITUIDO CON UN GRUPO R1. TAMBIEN SE DESCRIBEN COMPOSICIONES FARMACEUTICAS QUE CONTIENEN COMPUESTOS DE FORMULA (1.0). ADEMAS SE DESCRIBE UN METODO PARA TRATAR ASMA, ALERGIA E INFLAMACION MEDIANTE ADMINISTRACION DE UNA CANTIDAD EFECTIVA ANTI-ASMATICA, ANTI-ALERGICA O ANTI-INFLAMATORIA, RESPECTIVAMENTE DE UN COMPUESTO DE FORMULA (1.0).
ES93908326T 1992-03-27 1993-03-22 Derivados de bis-aril-carbinol sin enlaces de puente, composiciones y metodos de uso. Expired - Lifetime ES2089815T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85891992A 1992-03-27 1992-03-27

Publications (1)

Publication Number Publication Date
ES2089815T3 true ES2089815T3 (es) 1996-10-01

Family

ID=25329500

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93908326T Expired - Lifetime ES2089815T3 (es) 1992-03-27 1993-03-22 Derivados de bis-aril-carbinol sin enlaces de puente, composiciones y metodos de uso.

Country Status (13)

Country Link
US (2) US5679692A (es)
EP (1) EP0635012B1 (es)
JP (1) JPH07505393A (es)
AT (1) ATE140224T1 (es)
AU (1) AU3918993A (es)
CA (1) CA2132848A1 (es)
DE (1) DE69303605T2 (es)
DK (1) DK0635012T3 (es)
ES (1) ES2089815T3 (es)
GR (1) GR3021194T3 (es)
HK (1) HK31197A (es)
MX (1) MX9301721A (es)
WO (1) WO1993020063A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ249286A (en) * 1992-02-13 1996-02-27 Merrell Dow Pharma Piperidine-4-ylmethyl thiophene and thiazole derivatives and pharmaceutical compositions
WO2002089802A2 (en) 2001-05-08 2002-11-14 Schering Corporation Use of neurokinin receptor antagonists to treat androgen-dependent diseases
DK1423381T3 (da) 2001-09-06 2007-05-07 Schering Corp 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
AR036812A1 (es) * 2001-10-17 2004-10-06 Schering Corp Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de medicamentos para el tratamiento de enfermedades androgeno-dependientes
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) * 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
US7338967B2 (en) * 2004-09-10 2008-03-04 Syngenta Limited Substituted isoxazoles as fungicides

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA780443A (en) * 1968-03-12 Sandoz Patents Limited 10 h-(1) benzothiopyrano (3,2-b) pyridine derivatives
NL88063C (es) * 1950-12-05
US2898339A (en) * 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
GB1046543A (en) * 1963-02-22 1966-10-26 Sandoz Ag Improvements in or relating to azathiaxanthene derivatives
NL132137C (es) * 1963-04-24
BE638971A (es) * 1963-10-21
US3325501A (en) * 1964-02-18 1967-06-13 Sandoz Ltd 9-[piperidylidene(4')]-1-aza-thiaxanthene-10-oxides and derivatives
US3803154A (en) * 1969-08-07 1974-04-09 Colgate Palmolive Co 11-cyclicaminoalkylidenemorphanthridines
US3803153A (en) * 1970-11-16 1974-04-09 Schering Corp Benzopyrano pyridines
US3717647A (en) * 1971-04-09 1973-02-20 Schering Corp Alpha-nicotinoyl phenylacetonitriles
US4105849A (en) * 1974-09-30 1978-08-08 G. D. Searle & Co. [(Substituted )phenyl]phenylmethyl-1-(dialkylaminoalkyl)piperidines
US3922276A (en) * 1974-12-11 1975-11-25 Robins Co Inc A H 1-Substituted-4-benzylidenepiperidines
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US4032642A (en) * 1974-12-11 1977-06-28 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US3966944A (en) * 1975-05-19 1976-06-29 Abbott Laboratories 10 (N-methyl-4-piperidylidene)-10H[1]-benzopyrano[3,2-b]-pyridine as an analgesic, anti-inflammatory and agent against type III hypersensitivity disease
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US4355036A (en) * 1980-06-19 1982-10-19 Schering Corporation Tricyclic-substituted piperidine antihistamines
ATE13297T1 (de) * 1980-09-02 1985-06-15 Sandoz Ag Piperidyliden-derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4360483A (en) * 1981-08-10 1982-11-23 Ppg Industries, Inc. Apparatus for and method of pressing plastic sheets
JPS58171918A (ja) * 1982-04-01 1983-10-08 Asahi Chem Ind Co Ltd 強靭なるアクリルシ−ト
JPS59118765A (ja) * 1982-12-24 1984-07-09 Fujisawa Pharmaceut Co Ltd ピペラジン誘導体
US4540780A (en) * 1983-06-02 1985-09-10 Warner-Lambert Company Diphenylmethylene piperidines
JPS61501205A (ja) * 1984-02-15 1986-06-19 シェリング・コ−ポレ−ション ８↓−クロル↓−６，１１↓−ジヒドロ↓−１１↓−（４↓−ピペリジリデン）↓−５Ｈ↓−ベンゾ〔５，６〕シクロヘプタ〔１，２−ｂ〕ピリジンおよびその塩、これらの化合物の製造方法、ならびにこれらの化合物を含有する医薬組成物
US4628095A (en) * 1985-06-05 1986-12-09 G. D. Searle & Co. Substituted N-benzyl-4-(benzhydryl) piperidines
US4632925A (en) * 1985-10-07 1986-12-30 Hoffmann-La Roche Inc. N-substituted diphenylpiperidines and antiobesity use thereof
US4810713A (en) * 1985-12-20 1989-03-07 A. H. Robins Company, Incorporated Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl groups used in a method for allergy treatment
EP0235463A3 (en) * 1985-12-20 1990-01-17 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) N-substituted-arylalkyl and arylalkylene piperidines as cardiovascular antihistaminic and antisecretory agents
IL78939A (en) * 1986-01-17 1990-04-29 Robins Co Inc A H Pharmaceutical compositions containing n-substituted arylalkyl-and arylalkylene-piperidines and tetrahydropyridines and certain such novel compounds
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US5028610A (en) * 1987-03-18 1991-07-02 Sankyo Company Limited N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
US4797489A (en) * 1987-12-02 1989-01-10 American Home Products Corp. Adamantyl- and fluorenyl-arylpiperazines and -arylpiperidines
US4835157A (en) * 1988-03-15 1989-05-30 Ortho Pharmaceutical Corporation Thieno- and furopyrimidine-2,4-dione piperidine derivatives as serotonin antagonists and alpha adrenergic blocking agents
NZ228888A (en) * 1988-04-28 1991-12-23 Schering Corp Derivatives of piperidine, piperidylidene and piperazine and pharmaceutical compositions
ES2091195T3 (es) * 1988-04-28 1996-11-01 Schering Corp Compuestos policiclicos condensados, composiciones, metodos de preparacion y su uso como agentes antagonistas de paf, antihistaminicos y/o antiinflamatorios.
CA2004211A1 (en) * 1988-11-30 1990-05-31 Masataka Syoji Piperidine derivatives and hyportensives containing the same
US4994456A (en) * 1989-03-01 1991-02-19 Nisshin Flour Milling Co., Ltd. Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
GB9000304D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Muscarinic receptor antagonists
DE69027197T2 (de) * 1990-01-19 1996-11-21 Pharmacia Ab Intraoculare Linse mit Haltebügeln hoher Festigkeit
US5037435A (en) * 1990-03-02 1991-08-06 Optical Radiation Corporation Haptics for intraocular lenses having high fracture toughness
FR2665160A1 (fr) * 1990-07-26 1992-01-31 Esteve Labor Dr Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments.
DK0553191T3 (da) * 1990-10-10 1995-08-07 Schering Corp Pyridin- og pyridin-N-oxidderivater af diarylmethylpiperidiner eller -piperaziner, præparater og an vendelse deraf
FR2673574B1 (fr) * 1991-03-06 1994-11-04 Pierre Delamare Procede de fabrication de disques de polissage et disques ainsi obtenus.
US5169569A (en) * 1991-08-05 1992-12-08 Richard Ingram Method of making a one-piece intraocular lens

Also Published As

Publication number Publication date
GR3021194T3 (en) 1996-12-31
WO1993020063A1 (en) 1993-10-14
DE69303605D1 (de) 1996-08-14
EP0635012A1 (en) 1995-01-25
EP0635012B1 (en) 1996-07-10
DK0635012T3 (da) 1996-08-19
MX9301721A (es) 1993-09-01
CA2132848A1 (en) 1993-10-14
DE69303605T2 (de) 1997-01-23
US5679692A (en) 1997-10-21
HK31197A (en) 1997-03-21
ATE140224T1 (de) 1996-07-15
US5665735A (en) 1997-09-09
AU3918993A (en) 1993-11-08
JPH07505393A (ja) 1995-06-15

Similar Documents

Publication Publication Date Title
ES2133410T3 (es) Derivados sustituidos de la tiazolidindiona.
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
DE59009351D1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
UY24555A1 (es) Nuevos compuestos
ES2175127T3 (es) Derivados de la quinazolina y su uso.
ES2100151T3 (es) Nuevos derivados de benzopirano, procedimientos para su preparacion y su uso y composiciones que contienen los compuestos.
AR003116A1 (es) Compuestos triciclicos utiles para inhibir la funcion de la proteina g y para el tratamiento de enfermedades proliferativas, composicion farmaceutica que los comprende y el uso de dichos compuestos para la manufactura de medicamentos
ES2145254T3 (es) Formulaciones de aerosoles que contienen flunisolida.
MX9102501A (es) Derivados de metano sulfonamida, composiciones farderivados de metanosulfonamida, composiciones farmaceuticas que los contienen y procedimiento para smaceuticas que los contienen y procedimiento para u preparacion. su preparacion.
GEP20043237B (en) Pyrazoline Derivatives, Method for Their Preparation and Compositions Containing Them for Treatment of Diseases Mediated by Cyclooxygenase-2
IT1209603B (it) Derivati 2,6-disostituiti di naftalene, procedimento per prepararli e loro uso nel campo farmaceutico e cosmetico.
MX9302957A (es) Compuestos de xantina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9202152A (es) Derivados del indol, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2089815T3 (es) Derivados de bis-aril-carbinol sin enlaces de puente, composiciones y metodos de uso.
IT8322572A0 (it) Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
AR003451A1 (es) Derivados de piperazina, una composicion farmaceutica que los comprende, el uso de los mismos y un metodo para su preparacion.
ECSP941120A (es) Derivados de 1,5 benzodiazepina
MX9301157A (es) Derivados de bencimidazolona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2039292T3 (es) Derivados de piranobenzoxadiazol, preparacion de los mismos, utilizacion y compuestos que los comprenden.
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
ES2093301T3 (es) Nuevos oxialquinos, medicamentos que los contienen y procedimiento de preparacion de ambos.
IT8424187A0 (it) Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
MX18027A (es) Procedimiento para la preparacion de derivados de nitroxialquilamina productos obtenidos y composiciones farmaceuticas que los incluye.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 635012

Country of ref document: ES

FG2A Definitive protection

Ref document number: 635012

Country of ref document: ES